Redirecting to https://www.janssen.com/us/sites/www_janssen_com_usa/files/us_fda_approves_akeega_niraparib_and_abiraterone_acetate_the_first-and-only_dual_action_tablet_for_the_treatment_of_patients_with_brca-positive_metastatic_castration-resistant_prostate_cancer.pdf...

Click here if your browser doesn't automatically take you to this page.